Background: High-flow nasal cannula (HFNC) and noninvasive ventilation (NIV) are
important treatment approaches for acute hypoxemic respiratory failure (AHRF) in …

Background: During the novel coronavirus disease 2019 (COVID-19) pandemic raging
around the world, the effectiveness of respiratory support treatment has dominated people's …

BACKGROUND: High-flow nasal cannula (HFNC) oxygen and noninvasive ventilation (NIV)
have been widely used in patients with acute hypoxic respiratory failure (AHRF) due to …

Background: High-flow nasal cannula (HFNC) and conventional oxygen therapy (COT) are
important respiratory support strategies for acute hypoxemic respiratory failure (AHRF) in …

Background Acute respiratory failure (ARF) is a major adverse event commonly encountered
in severe coronavirus disease 2019 (COVID-19). Although noninvasive mechanical …

Background: Coronavirus disease 2019 (COVID-19) has spread globally, and many patients
with severe cases have received oxygen therapy through a high-flow nasal cannula (HFNC) …

Background The use of high-flow nasal cannula (HFNC) and noninvasive ventilation (NIV) in
patients with COVID-19 is debated. Methods This study was performed in four hospitals of …

BACKGROUND: Efficacy of high-flow nasal cannula (HFNC) over noninvasive ventilation
(NIV) in severe coronavirus disease 2019 (COVID-19) pneumonia is not known. We aimed …

Background: Early use of high-flow nasal cannula (HFNC) decreases the need for
endotracheal intubation (EI) in different respiratory failure causes. While HFNC is used in …

BACKGROUND: The use of high-flow nasal cannula (HFNC) and noninvasive ventilation
(NIV) for hypoxemic respiratory failure secondary to COVID-19 are recommended by critical …